Neuroendocrine tumors and rare gastrointestinal malignancies represent a diverse and complex group of diseases with variable clinical behavior. Improved awareness, advanced imaging, and biomarker development have led to increased detection. Accurate classification and staging are essential for appropriate management. Treatment often requires individualized strategies involving surgery, endoscopic therapy, systemic treatment, and targeted approaches. Long-term surveillance is critical due to the risk of recurrence and progression. This topic addresses diagnostic challenges, evolving therapeutic options, and multidisciplinary management of rare GI cancers.
Title : Gut mucosal immunity and inflammatory bowel disease
Youcun Qian, University of Chinese Academy of Sciences, China
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : The efficacy of fermented foods as an adjunct therapy in ulcerative colitis - a literature review
Jack D Doorly, Alfred Health, Australia
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Differentiating simple and aggressive phenotypes of metabolic dysfunction-associated steatotic liver disease utilizing bioelectrical impedance-derived metabolic age gap
Yury Marakhouski, Belarusian State Medical University, Belarus